Renin-angiotensin system genes polymorphism in Egyptians with premature coronary artery disease

Gene

Volumn 498, Issue 2, 2012, Pages 270-275

  Abd El Aziz, Tarek A ^a   Hussein, Yousri M ^a   Mohamed, Randa H ^a   Shalaby, Sally M ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Genetic polymorphism; Premature CAD; RAS

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EGYPTIAN; ETHNIC GROUP; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ONCOGENE RAS; POLYMERASE CHAIN REACTION; PREMATURE CORONARY ARTERY DISEASE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOKING;

ADULT; AGED; ANGIOTENSINOGEN; CHOLESTEROL; CORONARY ARTERY DISEASE; EGYPT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; SMOKING; TRIGLYCERIDES;

EID: 84858747461     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.02.033     Document Type: Article

References (43)

1. Agirbasli M., et al. Multifactor dimensionality reduction analysis of MTHFR, PAI-1, ACE, PON1, and eNOS gene polymorphisms in patients with early onset coronary artery disease. Eur. J. Cardiovasc. Prev. Rehabil. 2011, 22:21450592. (Feb 22).
2. Alvarez R., et al. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease. Cardiovasc. Res. 1998, 40:375-379.
3. Assali A., et al. Association between angiotensin II type-1 receptor A1166C polymorphism and the presence of angiographically-defined coronary artery disease in an Iranian population. Asian Biomedicine 2010, 4(2):307-314.
4. Batalla A., et al. Synergistic effect between apolipoprotein E and angiotensinogen gene polymorphisms in the risk for early myocardial infarction. Clin. Chem. 2000, 46:1910-1915.
5. Berge K.E., et al. A DNA polymorphism at the angiotensin II type 1 receptor (AT1R) locus and myocardial infarction. Clin. Genet. 1997, 52:71-76.
6. Carmena R., et al. The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism. Metabolism 1993, 42:895-901.
7. Caulfield M., et al. Linkage of the angiotensinogen gene to essential hypertension. N. Engl. J. Med. 1994, 330:1629-1633.
8. Curnow K.M., et al. Genetic analysis of the human type-1 angiotensin receptor. Mol. Endocrinol. 1992, 6:1113-1118.
9. Danser A.H., et al. Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 1995, 92:1387-1388.
10. Danser A.H.J., et al. Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma rennin and prorenin levels. J. Hypertens. 1998, 16:1879-1883.
11. Dzida G., et al. Polymorphisms of angiotensin-converting enzyme and angiotensin II receptor type 1 gene in essential hypertension in a Polish population. Med. Sci. Monit. 2001, 7:1236-1241.
12. Dzimiri N., et al. Angiotensin-converting enzyme polymorphism and the risk of coronary heart disease in the Saudi male population. Arch. Pathol. Lab. Med. 2000, 124(4):531-534.
13. Ermis C., et al. Angiotensin I converting enzyme, angiotensin II type I receptor and angiotensinogen polymorphisms and early myocardial infarction in Turkish population. Thromb. Haemost. 2002, 88:693-694.
14. Fatini C., et al. Searching for a better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms. Eur. Heart J. 2000, 21:633-638.
15. Freitas A.I., et al. RAS gene polymorphisms, classical risk factors and the advent of coronary artery disease in the Portuguese population. BMC Cardiovasc. Disord. 2008, 8:15.
16. Frieldewald W.T., et al. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18:499-502.
17. Hamsten A., Eriksson P. Identifying the susceptibility genes for coronary artery disease: from hyperbole through doubt to cautious optimism. J. Intern. Med. 2008, 263(5):538-552.
18. Hauser E.R., et al. Design of the Genetics of Early Onset Cardiovascular Disease (GENECARD) study. Am. Heart J. 2003, 145:602-613.
19. Hoshida S., et al. Increased angiotensin-converting enzyme activity in coronary artery specimens from patients with acute coronary syndrome. Circulation 2001, 103(5):630-633.
20. Igic R., Behnia R. Properties and distribution of angiotensin I converting enzyme. Curr. Pharm. Des. 2003, 9(9):697-706.
21. Jurkovicova D., et al. Cardiovascular diseases and molecular variants of the renin-angiotensin system components in Slovak population. Gen. Physiol. Biophys. 2007, 26(1):27-32.
22. Katsuya T., et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995, 345:1600-1603.
23. Keavney B., et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls: International Studies of Infarct Survival (ISIS) Collaborators. Lancet 2000, 355:434-442.
24. Kretowski A., et al. Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis. Diabetes 2007, 56:863-871.
25. Kuo L.T., et al. Relation between M235T polymorphism of the angiotensinogen gene and coronary artery disease in Taiwanese: an angiography-controlled study. Acta Cardiol. Sin. 2008, 24:75-79.
26. Nakauchi Y., et al. Significance of angiotensin I-converting enzyme and angiotensin II type 1 receptor gene polymorphisms as risk factors for coronary heart disease. Atherosclerosis 1996, 125:161-169.
27. Niemec P., et al. Modification of the coronary artery disease risk associated with the presence of traditional risk factors by insertion/deletion polymorphism of the ACE gene. Genet. Test. 2007, 11:353-359.
28. Niemiec P., et al. The M235T polymorphism of the AGT gene modifies the risk of coronary artery disease associated with the presence of hypercholesterolemia. Eur. J. Epidemiol. 2008, 23:349-354.
29. Qiu C., et al. Association of polymorphisms in angiotensin-converting enzyme and type 1 angiotensin II receptor genes with coronary heart disease and the severity of coronary artery stenosis. J. Huazhong Univ. Sci. Technol. Med. Sci. 2008, 27:660-663.
30. Renner W., et al. Association of angiotensinogen haplotypes with angiotensinogen levels but not with blood pressure or coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study. J. Mol. Med. 2005, 83:235-239.
31. Rigat B., et al. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992, 20:1433.
32. Rodriguez-Perez J.C., et al. Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study. Prospective Cardiac Gene. J. Am. Coll. Cardiol. 2001, 37(6):1536-1542.
33. Sato N., et al. Nine polymorphisms of angiotensinogen gene in the susceptibility to essential hypertension. Life Sci. 2000, 68:259-272.
34. Sekuri C., et al. Renin-angiotensin system gene polymorphisms and premature coronary heart disease. J. Renin Angiotensin Aldosterone Syst. 2005, 6:38-42.
35. Sethi A.A., et al. Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Ann. Intern. Med. 2001, 134:941-954.
36. Sethi A.A., et al. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler. Thromb. Vasc. Biol. 2003, 23(7):1269-1275.
37. Shafiee S.M., et al. Angiotensin converting enzyme DD genotype not associated with increased risk of coronary artery disease in the Iranian population. Pathophysiology 2010, 17(3):163-167.
38. Shaker O.G., et al. Angiotensinogen gene (M235T) polymorphism and coronary artery disease in the Egyptian population. A genetic association study. Heart Mirror J. 2009, 3(2):86-91.
39. Vaisi-Raygani A., et al. Variant and the APOE-ε4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients. Mol. Biol. Rep. 2010, 37:2083-2091.
40. Vaisi-Raygani A., et al. The angiotensin converting enzyme D allele is an independent risk factor for early onset coronary artery disease. Clin. Biochem. 2010, 43:1189-1194.
41. Xu M.Q., et al. Quantitative assessment of the effect of angiotensinogen gene polymorphisms on the risk of coronary heart disease. Circulation 2007, 116:1356-1366.
42. Xu M., et al. A1166C genetic variation of the angiotensin II type I receptor gene and susceptibility to coronary heart disease: collaborative of 53 studies with 20,435 cases and 23,674 controls. Atherosclerosis 2010, 213:191-199.
43. Zintzaras E., et al. Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch. Intern. Med. 2008, 168(10):1077-1089.